Oral corticosteroids are the main therapeutic choice for systemic lupus ery
thematosus (SLE). Adverse reactions to systemic corticosteroids rarely occu
r and the etiology is unclear in most cases. A 14-year-old girl with newly
diagnosed SLE developed a pruritic bullous eruption while on prednisone. Th
e patient had been treated successfully in the hospital with intravenous me
thylprednisolone. In preparation for discharge, the steroid preparation was
changed to prednisone to which the patient reacted with a development of n
ew crops of bullous lesions. Skin biopsy specimens of lesional areas showed
a bullous eruption consistent with erythema multiforme. The patient underw
ent immediate and delayed hypersensitivity tests. Intradermal and patch tes
ts to liquid prednisone were positive. The patient was discharged on oral m
ethylprednisolone and has not had recurrence of the skin lesions. In conclu
sion, a case of prednisone sensitivity in a patient with SLE is presented h
ere. An alternative preparation, methylprednisolone, was used to successful
ly treat her underlying condition.